Furthermore, findings from reporter luciferase experiments and chromatin immunoprecipitation (ChIP) studies have indicated that YBX1 binds to the Cyclin D1 promoter, enhancing its expression at both the protein and mRNA levels in lung cancer cells and neuroblastoma cells [46,47]. The gene discussed is YBX1; the disease is lung cancer.